AVR Anteris Technologies Global Corp.

AMX
$9.40

Anteris Technologies Global Corp. (AVR) is expected to report earnings on November 10, 2026, after the market close. The stock has had a Post-Earnings Announcement Drift (PEAD) of +4.1% since its last earnings release on August 11, 2026.

Anteris Technologies Global Reported Earnings
Tuesday, August 11, 2026 · 7:00 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 10
Tuesday · 7:00 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $9.07

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Anteris Technologies Global Corp.

Anteris Technologies Global Corp. is involved in designing, developing and commercializing cutting-edge medical devices to restore healthy heart function. The company's lead product includes DurAVR(R). Anteris Technologies Global Corp. is based in BRISBANE, Australia.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 1 ETFs, by dollar flow